Edap Tms SA (NASDAQ:EDAP) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 114,100 shares, an increase of 119.8% from the September 30th total of 51,900 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 222,500 shares, the days-to-cover ratio is presently 0.5 days.
EDAP has been the topic of several research reports. ValuEngine lowered shares of Edap Tms from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Zacks Investment Research lowered shares of Edap Tms from a “buy” rating to a “hold” rating in a research report on Tuesday. Finally, HC Wainwright set a $7.00 price objective on shares of Edap Tms and gave the stock a “buy” rating in a research report on Friday, August 30th.
Shares of EDAP stock opened at $4.62 on Wednesday. The firm has a market cap of $127.88 million, a price-to-earnings ratio of 231.00 and a beta of 1.84. Edap Tms has a 52 week low of $1.35 and a 52 week high of $5.42. The firm’s 50-day simple moving average is $4.64 and its two-hundred day simple moving average is $3.65.
Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings data on Wednesday, August 28th. The medical equipment provider reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. The business had revenue of $14.04 million for the quarter, compared to analyst estimates of $11.92 million. Edap Tms had a net margin of 4.57% and a return on equity of 23.31%. As a group, analysts expect that Edap Tms will post 0.18 earnings per share for the current year.
Hedge funds have recently made changes to their positions in the business. Acadian Asset Management LLC bought a new stake in Edap Tms in the second quarter worth about $607,000. Fosun International Ltd raised its position in shares of Edap Tms by 9.4% in the second quarter. Fosun International Ltd now owns 397,568 shares of the medical equipment provider’s stock valued at $1,145,000 after purchasing an additional 34,083 shares during the period. JPMorgan Chase & Co. bought a new stake in shares of Edap Tms in the second quarter valued at approximately $282,000. Morgan Stanley raised its position in shares of Edap Tms by 222.7% in the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock valued at $722,000 after purchasing an additional 184,539 shares during the period. Finally, Susquehanna International Group LLP raised its position in shares of Edap Tms by 762.9% in the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after purchasing an additional 181,401 shares during the period. 13.27% of the stock is currently owned by institutional investors and hedge funds.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Further Reading: No Load Funds
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.